# GRIT-Atlas: A Comprehensive Treatment-Induced Resistance Atlas of Glioblastoma

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.18009414.svg)](https://doi.org/10.5281/zenodo.18009414)
[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](https://opensource.org/licenses/MIT)

This repository contains the complete computational pipeline for the **Glioblastoma Resistance Insights from Treatment Atlas (GRIT-Atlas)**. Our study utilizes an integrated single-cell and spatially resolved multi-omic approach to deconstruct the cellular and spatial logic of therapy-induced evolution in IDH-wildtype glioblastoma.

## ðŸŒŸ Scientific Highlights
* **Scale and Scope**: We constructed a high-resolution integrated atlas encompassing **978,065 cells** from **296 samples**, capturing the full spectrum of disease evolution from primary diagnosis to recurrence post-standard-of-care and combinatorial immunotherapy.
* **The Spatial Resistance Triad**: Using spatial transcriptomics across 48 patient sections, we identified a core functional unit composed of **cNMF7 (MES-like)** malignant cells, differentiation-arrested **E-MDSCs**, and Type VI Collagen-secreting **myCAFs**.
* **Niche-Specific Resistance**: This triad specifically colonizes the hypoxic microvascular proliferation (**MVP**) and pseudopalisading necrosis (**PAN**) niches.
* **Mechanistic Insight**: We demonstrate that myCAFs function as stromal architects, constructing a fibrotic scaffold via the **Collagen/Fibronectin-CD44 signaling axis** to physically exclude cytotoxic T cells and sustain malignant plasticity.

---

## ðŸ“‚ Repository Organization

The analysis is modularized into four key computational stages:

| Script Name | Analysis Module | Primary Methodology | Linked Data Files |
| :--- | :--- | :--- | :--- |
| `1_Single_Cell_Preprocessing.ipynb` | Atlas Construction | QC, Covariate Regression, BBKNN | `IntegratedData.zip` |
| `2_Malignant_cNMF_Analysis.ipynb` | Malignant Phenotyping | Consensus NMF (cNMF) | `Malignant.qs` |
| `3_Spatial_Landscape_Analysis.R` | Spatial Modeling and Signaling & Gradients | RCTD & MistyR & SPATA2 | `GRIT-Atlas_RCTDres.zip`, `Merge_RCTDInput.qs` |
| `4_Niche_Validation.R` | Niche communications | Lineage-specific files |  `CellChat.zip` |

---

## ðŸ“Š Data Access (Zenodo)

All processed data objects required to reproduce the findings are hosted on **Zenodo**:
ðŸ”— **[DOI: 10.5281/zenodo.18009414](https://doi.org/10.5281/zenodo.18009414)**

### 1. Global Integrated Data
* **`IntegratedData.zip`**: The master Seurat/AnnData object for the complete GRIT-Atlas (978,065 cells). Includes batch-corrected UMAP coordinates, treatment status (pGBM, rGBM-R+C, rGBM-ICB, rGBM-ICB+Target), clinical response, and lineage annotations.

### 2. High-Resolution Lineage Objects
* **`Malignant.qs`**: Details 11 functional states (cNMF), including the resistance-associated **cNMF7 (MES-like)** state and Neuron-like (NEU) states.
* **`Myeloid.zip`**: High-resolution subclustering of 349,583 myeloid cells (23 subpopulations), highlighting **E-MDSC.ADM.HIF1A** and Mono.CD14.FCGR3A.
* **`Lymphocyte.zip`**: Detailed annotations for 36 lymphoid subsets, including cytotoxic T cells, exhausted T cells (**Tex.03.ALDOA.MIF**), and Tregs.
* **`Stroma.qs`**: Processed stromal compartment (CAFs, Pericytes, SMCs), specifically annotating the **myCAF.02.COL6** subset.
* **`Endothelial.qs`**: High-resolution mapping of ECs, characterizing immune-resistant subsets (**Vein.VCAM1** and **Arterial.01.DKK2**).

### 3. Spatial Transcriptomics & Communication
* **`GRIT-Atlas_RCTDres.zip`**: RCTD weight matrices and MistyR importance values for 48 glioblastoma patient sections (10x Visium).
* **`Merge_RCTDInput.qs`**: Optimized scRNA-seq reference object used for RCTD deconvolution.
* **`CellChat.zip`**: Processed objects documenting communication within the "Spatial Resistance Triad." Includes sub-objects for **Secreted Signaling**, **ECM-Receptor** (e.g., Collagen-CD44 axis), and **Cell-Cell Contact**.

---

## ðŸ’» Software Requirements

### **Python Environment (v3.10+)**
Used for atlas construction and malignant state characterization:
* `scanpy` (v1.10.1): QC and normalization.
* `bbknn` (v1.6.0): Large-scale batch correction.
* `omicverse` (v1.6.10): Pearson residuals scaling and cNMF decomposition.
* `infercnvpy` (v0.5.0): CNV-based malignant cell identification.

### **R Environment (v4.3+)**
Used for spatial modeling and signaling inference:
* `Seurat` (v4.3.0): Core framework.
* `spacexr` (RCTD v2.2.0): Cell type deconvolution.
* `mistyR` (v1.10.0): Multi-view spatial relationship inference.
* `CellChat` (v1.6.1): Ligand-receptor communication modeling.
* `SPATA2` (v3.1.0): Niche-specific histological gradient screening.

---

## ðŸ“ Citation

If you utilize the GRIT-Atlas code or data, please cite our manuscript:

> **Wang F, et al.** (2025). *A Comprehensive Treatment-Induced Resistance Atlas of Glioblastoma Reveals a Fibrotic Niche Shielding the Tumor from Immunotherapy.*

**Contact**:
**Fei Wang, MD**
Department of Neurosurgery & Brain and Nerve Research Laboratory
The First Affiliated Hospital of Soochow University
Email: [wangfeineu@163.com](mailto:wangfeineu@163.com)

---
**License**: 
* **Code**: MIT License.
* **Data**: Creative Commons Zero (CC0) / Public Domain.
